Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/12/1995 | US5474901 Specifically binds human carboxypeptidase |
12/12/1995 | US5474898 Octopamine receptor |
12/12/1995 | US5474896 Nucleotide sequence encoding the enzyme I-SceI and the uses thereof |
12/12/1995 | US5474890 Method for inducing the acrosome reaction in human and animal spermatozoa |
12/12/1995 | US5474796 Immobilization |
12/12/1995 | US5474773 Human rotaviruses, vaccines and method |
12/12/1995 | US5474771 Inhibits T cell activation of B cells ; binds to epitope |
12/12/1995 | CA1337717C Monoclonal antibodies against human necrosis factor (tnf) _ use thereof for detecting tnf in samples, and pharmaceutical compositions containing them |
12/12/1995 | CA1337716C Universal dominant selectable marker cassette |
12/11/1995 | CA2151446A1 Modified satellite rnas and satellite viruses as carriers of adapted ribozymes |
12/09/1995 | CA2151065A1 Apparatus and method for determining the characteristics of the concentration growth of target nucleic acid molecules in polymerase chain reaction sample |
12/07/1995 | WO1995033297A1 Electromagnetically controlled gear engagement mechanism integrated with a magnetic hysteresis slip clutch |
12/07/1995 | WO1995033073A1 Producing copies of nucleic acids |
12/07/1995 | WO1995033062A2 Method for introducing foreign matter into higher eukaryotic cells |
12/07/1995 | WO1995033061A1 Method for introducing nucleic acid in higher eukaryotic cells |
12/07/1995 | WO1995033060A1 Method of cancer treatment by p53 protein control |
12/07/1995 | WO1995033059A2 Receptor for oncostatin m |
12/07/1995 | WO1995033058A1 Gene coding for modified bone morphogenic protein receptor |
12/07/1995 | WO1995033057A1 Hybrid molecule of formula gm-csf-l-epo or epo-l-gm-csf for hematopoietic stimulation |
12/07/1995 | WO1995033056A1 Dna encoding the bacillus licheniformis pwd-1 keratinase |
12/07/1995 | WO1995033055A2 Wax esters in transformed plants |
12/07/1995 | WO1995033054A1 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE |
12/07/1995 | WO1995033053A1 Hepatitis c virus asialoglycoproteins |
12/07/1995 | WO1995033052A1 Immunosuppressant target proteins |
12/07/1995 | WO1995033051A1 Tumor necrosis factor receptor-associated factors |
12/07/1995 | WO1995033050A1 Flt-4 (fms-like tyrosine-kinase), flt-15, variants thereof uses as growth factor inhibitors |
12/07/1995 | WO1995033049A2 Tbp2 FRAGMENTS OF THE TRANSFERRINE RECEPTOR OF NEISSERIA MENINGITIDIS |
12/07/1995 | WO1995033048A2 P2x receptors (purinoceptor family) |
12/07/1995 | WO1995032992A1 Synthetic peptide analogs of lung surfactant protein sp-c |
12/07/1995 | WO1995032988A1 Novel parasite protease genes and proteins |
12/07/1995 | WO1995032987A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION |
12/07/1995 | WO1995032986A1 Branched oligonucleotides as pathogen-inhibitory agents |
12/07/1995 | WO1995032982A1 Dna encoding gls1 |
12/07/1995 | WO1995032733A1 Method of inducing an immune response with a live venezuelan equine encephalitis virus expressing a heterologous immunogen |
12/07/1995 | WO1995032731A2 Immunogenic pharmaceuticals |
12/07/1995 | WO1995032724A1 Glial mitogenic factors, their preparation and use |
12/07/1995 | WO1995032706A1 Virosome-mediated intracellular delivery of therapeutic agents |
12/07/1995 | WO1995032628A1 Oligonucleotide inhibitors of cytokine production and tumors responsive to cytokines |
12/07/1995 | WO1995032627A1 Use of fas ligand to suppress lymphocyte-mediated immune responses |
12/07/1995 | WO1995024485A3 Coordinate in vivo gene expression |
12/07/1995 | WO1995021919A3 Protein having tpo activity |
12/07/1995 | WO1995020669A3 Soybean cyst nematode resistant soybeans and methods of breeding and identifying resistant plants |
12/07/1995 | DE4435919C1 DNA encoding zinc finger protein |
12/07/1995 | DE4419294A1 Legionella pneumophila DNA coding for major outer membrane protein |
12/07/1995 | DE4418965A1 Transfection of eukaryotic cells with nucleic acid |
12/07/1995 | DE4418825A1 Transfection of eukaryotic cells |
12/07/1995 | CA2191762A1 Method for introducing nucleic acid in higher eukaryotic cells |
12/07/1995 | CA2191426A1 Producing copies of nucleic acids |
12/07/1995 | CA2191321A1 Gene coding for modified bone morphogenic protein receptor |
12/07/1995 | CA2191306A1 Hybrid molecule of formula gm-csf-l-epo or epo-l-gm-csf for hematopoietic stimulation |
12/07/1995 | CA2191085A1 Glial mitogenic factors, their preparation and use |
12/07/1995 | CA2191071A1 Flt-4 (fms-like tyrosine kinase), flt-15, variants thereof used as growth factor inhibitors |
12/07/1995 | CA2191067A1 Dna encoding gls1 |
12/07/1995 | CA2190998A1 Branched oligonucleotides as pathogen-inhibitory agents |
12/07/1995 | CA2190963A1 Method for introducing foreign matter into higher eukaryotic cells |
12/07/1995 | CA2190265A1 Hepatitis c virus asialoglycoproteins |
12/07/1995 | CA2190254A1 Tumor necrosis factor receptor-associated factors |
12/07/1995 | CA2189741A1 Novel parasite protease genes and proteins |
12/07/1995 | CA2188449A1 Electromagnetically controlled gear engagement mechanism integrated with a magnetic hysteresis slip clutch |
12/07/1995 | CA2168042A1 Wax esters in transformed plants |
12/07/1995 | CA2167936A1 Tbp2 fragments of the transferrine receptor of neisseria meningitidis |
12/06/1995 | EP0685739A1 Method of detecting DAF molecules in feces |
12/06/1995 | EP0685560A2 Method for controlling gene expression |
12/06/1995 | EP0685558A1 Transgenic animals lacking proteolipid protein and method of making such animals |
12/06/1995 | EP0685557A1 Novel metalloprotease and dna coding for the same |
12/06/1995 | EP0685555A1 L-Isoleucine producing bacterium and method for preparing L-Isoleucine through fermentation |
12/06/1995 | EP0685490A1 Process for the purification of homogeneous platelet-derived endothelial cell growth factor from a platelet lysate |
12/06/1995 | EP0684999A1 Sequence-directed dna-binding molecules compositions and methods |
12/06/1995 | EP0684998A1 Altered linolenic and linoleic acid content in plants |
12/06/1995 | EP0684997A1 Anthrax toxin fusion proteins and uses thereof |
12/06/1995 | EP0684995A1 Brazzein sweetener |
12/06/1995 | EP0684994A1 A novel family of anti-carcinoembryonic antigen chimeric antibodies |
12/06/1995 | EP0684993A1 Human dna sequence encoding a kidney atp-dependent potassium channel |
12/06/1995 | EP0684992A1 Method for obtaining an increased production of a producing celline by using a fusion protocol |
12/06/1995 | EP0684990A1 Novel receptor-type phosphotyrosine phosphatase-gamma |
12/06/1995 | EP0684989A1 Novel receptor-type phosphotyrosine phosphatase-beta |
12/06/1995 | EP0684955A1 Nuclear matrix proteins |
12/06/1995 | EP0684954A1 Nucleic acid probes chemically 5'(oh)- and/or 3'(oh)-modified for inserting one or more non-radioactive labeling elements thereat, and method for preparing same |
12/06/1995 | EP0684952A1 Method for the immobilization of nucleic acid molecules |
12/06/1995 | EP0684842A1 Composition for use in the treatment of tumours and the immunization of humans and animals |
12/06/1995 | EP0684770A1 An enzyme feed additive and animal feed including it |
12/06/1995 | EP0684764A1 Treatment of androgen-associated baldness using antisense oligomers |
12/06/1995 | EP0684759A1 Transgenic pomaceous fruit with fire blight resistance |
12/06/1995 | EP0593580A4 Sequences characteristic of human gene transcription product |
12/06/1995 | EP0529076B1 Proteins with fibroblast growth factor receptor activity |
12/06/1995 | EP0466818B1 Monoclonal antibody recognizing a glycoprotein of human milk-fat globule membrane mucin antigen |
12/05/1995 | US5473060 Oligonucleotide clamps having diagnostic applications |
12/05/1995 | US5473052 Antigen-binding fragments of an antibody to type-I collagen amino-terminal telopeptide |
12/05/1995 | US5473051 Inhibition of Mac-1 receptor binding to fibrinogen using D30 homologs |
12/05/1995 | US5473049 Process for obtaining proinsulin possessing correctly linked cystine bridges |
12/05/1995 | US5472939 Method of treating complement mediated disorders |
12/05/1995 | US5472872 Purified, isolated polynucleotide encoding CviJI restriction endonuclease polypeptide or variant having same activity |
12/05/1995 | US5472871 Isolation and characterization of the nematode HER-1 Gene and protein product |
12/05/1995 | US5472870 Biologically pure culture of a strain of Xanthomonas compestris ATCC 55429 |
12/05/1995 | US5472869 Regenerated, fertile cells |
12/05/1995 | US5472868 Stable rabbit-mouse fusion partner |
12/05/1995 | US5472864 Method of preparing solution enriched in EG III using low molecular weight alcohol, organic salt and inorganic salt |
12/05/1995 | US5472857 DNA encoding canine granulocyte colony stimulating factor (G-CSF) |
12/05/1995 | US5472856 Recombinant human thymopoietin proteins and uses therefor |
12/05/1995 | US5472855 Substrate assisted catalysis |